Clinical Trials Directory

Trials / Completed

CompletedNCT03799705

Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway

Identifying Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway in Patients With Congenital Malformations

Status
Completed
Phase
Study type
Observational
Enrollment
132 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
0 Years
Healthy volunteers
Not accepted

Summary

Researchers are trying to identify versions of genes as well as factors in subjects blood associated with certain types of congenital malformations(CMs). This study will help the researchers to better understand family traits that contribute to CMs.

Conditions

Timeline

Start date
2019-12-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2019-01-10
Last updated
2024-04-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03799705. Inclusion in this directory is not an endorsement.

Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway (NCT03799705) · Clinical Trials Directory